RecruitingNCT06805474

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

Studying Best vitelliform macular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nanoscope Therapeutics Inc.
Principal Investigator
Samuel Barone, MD, MD
Nanoscope Therapeutics Inc.
Intervention
Observational(other)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
20252025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06805474 on ClinicalTrials.gov

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Best vitelliform macular dystrophy

← Back to all trials